NIPO trademark

Bristol-Myers Squibb Company design mark 202612770

FiledNIPOWord and designClass 5

"Application 202612770" is a word and design mark owned by Bristol-Myers Squibb Company, filed at the NIPO on October 20, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Bristol-Myers Squibb Company portfolioGet this data via the API
Official NIPO record
Bristol-Myers Squibb Company design mark 202612770 trademark as filed
As filed with the NIPO
Status
Filed
Since October 20, 2026
Filed
October 20, 2026
Registered
Not yet
Priority date
April 21, 2026
Claimed from United States
Application no.
202612770
Registration no.
Not yet
Office
NIPO
Patentstyret (Norwegian Industrial Property Office)
Mark type
Word and design
1 class
Ownership

Who owns Bristol-Myers Squibb Company design mark 202612770

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Bristol-Myers Squibb Company

BMY · Princeton, United States

6,627 trademarks in the portfolioView company

Representative

Acapo Onsagers AS

Acapo Onsagers AS

Goods and services

What the mark covers

The products and services Bristol-Myers Squibb Company design mark 202612770 is filed for, grouped by Nice class.

  • Farmasøytiske preparater for behandling og forebygging av fedme, hjerte- og karsykdommer, sykdommer i sentralnervesystemet, metabolske forstyrrelser, hjerneslag, kreft, inflammatoriske sykdommer, luftveissykdommer, infeksjonssykdommer, autoimmune sykdommer, avstøtning av transplanterte solide organer, autoinflammatoriske sykdommer, blodsykdommer, multippel sklerose, ulcerøs kolitt, cystisk fibrose, artritt, Alzheimers sykdom, autisme samt muskel- og skjelettsykdommer og hudsykdommer; antivirale midler; antistoffer til medisinsk bruk; biologiske preparater for behandling av kreft; antikoagulanter; stamceller til medisinsk bruk; radiofarmasøytiske preparater for behandling av kreft og solide svulster; diagnostiske radiofarmasøytiske preparater; diagnostiske preparater til medisinsk bruk.

FAQ

About Bristol-Myers Squibb Company design mark 202612770

Who owns the trademark "Application 202612770"?

The NIPO trademark "Application 202612770" (application 202612770) is owned by Bristol-Myers Squibb Company.

What is the status of "Application 202612770"?

Its status at the NIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Bristol-Myers Squibb Company design mark 202612770 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a15cad-5f2d-727a-bda0-a9c858e7922f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a15cad-5f2d-727a-bda0-a9c858e7922f",
  "object": "trademark",
  "mark_text": null,
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "NO",
  "application_number": "202612770",
  "filing_date": "2026-10-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Bristol-Myers Squibb Company",
      "entity_id": "ent_019eb6f6-138d-72ab-8c30-1f28aa1b6803"
    }
  ]
}